Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Simotinib Hydrochloride in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 25 Aug 2013
At a glance
- Drugs Simotinib (Primary)
- Indications Cancer
- Focus Adverse reactions
- 01 Jun 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Nov 2011 New trial record